1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 31-40 of 50 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2021Dual antiangiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II studyMooi, J.; Chionh, F.; Savas, P.; Da Gama Duarte, J.; Chong, G.; Brown, S.; Wong, R.; Price, T.J.; Wann, A.; Skrinos, E.; Mariadason, J.M.; Tebbutt, N.C.
2020Coal-mine fire-related fine particulate matter and medical-service utilization in Australia: a time-series analysis from the Hazelwood Health StudyJohnson, A.L.; Gao, C.X.; Dennekamp, M.; Williamson, G.J.; Carroll, M.T.C.; Dimitriadis, C.; Dipnall, J.F.; Ikin, J.F.; Johnston, F.H.; McFarlane, A.C.; Sim, M.R.; Stub, D.A.; Abramson, M.J.; Guo, Y.
2021Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemiaOchi, Y.; Yoshida, K.; Huang, Y.-J.; Kuo, M.-C.; Nannya, Y.; Sasaki, K.; Mitani, K.; Hosoya, N.; Hiramoto, N.; Ishikawa, T.; Branford, S.; Shanmuganathan, N.; Ohyashiki, K.; Takahashi, N.; Takaku, T.; Tsuchiya, S.; Kanemura, N.; Nakamura, N.; Ueda, Y.; Yoshihara, S.; et al.
2020Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019GBD 2019 Diseases and Injuries Collaborators,; Baune, B.; Bhandari, D.; Ciobanu, L.; Lalloo, R.; Lassi, Z.; Noubiap Nzeale, J.
2021Changes in 24-Hour physical activity patterns and walking gait biomechanics after primary total hip arthroplasty: a 2-year follow-up studyBahl, J.S.; Millar, S.C.; Fraysse, F.; Arnold, J.B.; Taylor, M.; Callary, S.; Solomon, L.B.; Thewlis, D.
2021AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerOar, A.; Lee, M.; Le, H.; Wilson, K.; Aiken, C.; Chantrill, L.; Simes, J.; Nguyen, N.; Barbour, A.; Samra, J.; Sjoquist, K.M.; Moore, A.; Espinoza, D.; Gebski, V.; Yip, S.; Chu, J.; Kneebone, A.; Goldstein, D.
2021Deletions in VANGL1 are a risk factor for antibody-mediated kidney disease.Jiang, S.H.; Mercan, S.; Papa, I.; Moldovan, M.; Walters, G.D.; Koina, M.; Fadia, M.; Stanley, M.; Lea-Henry, T.; Cook, A.; Ellyard, J.; McMorran, B.; Sundaram, M.; Thomson, R.; Canete, P.F.; Hoy, W.; Hutton, H.; Srivastava, M.; McKeon, K.; de la Rúa Figueroa, I.; et al.
2021Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesityCao, E.; Watt, M.J.; Nowell, C.J.; Quach, T.; Simpson, J.S.; De Melo Ferreira, V.; Agarwal, S.; Chu, H.; Srivastava, A.; Anderson, D.; Gracia, G.; Lam, A.; Segal, G.; Hong, J.; Hu, L.; Phang, K.L.; Escott, A.B.J.; Windsor, J.A.; Phillips, A.R.J.; Creek, D.J.; et al.
2021Large variability in plasma efavirenz concentration in Papua New Guinea HIV/AIDS patients associated with high frequency of CYP2B6 516T alleleBordin Andriguetti, N.; Van Schalkwyk, H.K.; Barratt, D.T.; Tucci, J.; Pumuye, P.; Somogyi, A.A.
2021γδ T cells in merkel cell carcinomas have a proinflammatory profile prognostic of patient survivalGherardin, N.A.; Waldeck, K.; Caneborg, A.; Martelotto, L.G.; Balachander, S.; Zethoven, M.; Petrone, P.M.; Pattison, A.; Wilmott, J.S.; Quiñones-Parra, S.M.; Rossello, F.; Posner, A.; Wong, A.; Weppler, A.M.; Shannon, K.F.; Hong, A.; Ferguson, P.M.; Jakrot, V.; Raleigh, J.; Hatzimihalis, A.; et al.

Discover